ID

36281

Description

A Single Arm, Tolerability and Safety Phase IV Study of Fulvestrant(Faslodex® ) as 2nd Line and Later Therapy in Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT02447328

Lien

https://clinicaltrials.gov/show/NCT02447328

Mots-clés

Versions (1)
  1. 29/04/2019 29/04/2019 -
Détendeur de droits

See clinicaltrials.gov

Téléchargé le

29 avril 2019

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Locally Advanced or NCT02447328

Anglais

Eligibility Locally Advanced or NCT02447328

1 Formulaires  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
postmenopausal women
Description

Postmenopausal state

Type de données

boolean

Alias
UMLS CUI [1]
C0232970
postmenopausal: amenorrhea over 12 months prior to the visit 1 or history of hysterectomy ２) outpatient or inpatient with locally advanced or metastatic breast cancer who have failed with prior anti-estrogen therapy.
Description

Postmenopausal state | Amenorrhea Duration | Hysterectomy | Outpatients | Inpatient | Locally advanced breast cancer | Secondary malignant neoplasm of female breast | Prior antiestrogen therapy failed

Type de données

boolean

Alias
UMLS CUI [1]
C0232970
UMLS CUI [2,1]
C0002453
UMLS CUI [2,2]
C0449238
UMLS CUI [3]
C0020699
UMLS CUI [4]
C0029921
UMLS CUI [5]
C0021562
UMLS CUI [6]
C3495949
UMLS CUI [7]
C0346993
UMLS CUI [8,1]
C0279797
UMLS CUI [8,2]
C0231175
estrogen receptor positive ４)radiographic progression of disease after the prior therapy ５) patients who agree to participate in this study and sign the informed consent
Description

Patients Estrogen receptor positive | Disease Progression Radiography | Status post Prior Therapy | Informed Consent

Type de données

boolean

Alias
UMLS CUI [1,1]
C0030705
UMLS CUI [1,2]
C0279754
UMLS CUI [2,1]
C0242656
UMLS CUI [2,2]
C0034571
UMLS CUI [3,1]
C0231290
UMLS CUI [3,2]
C1514463
UMLS CUI [4]
C0021430
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
patients who are treated with fulvestrant
Description

fulvestrant

Type de données

boolean

Alias
UMLS CUI [1]
C0935916
patients who are being treated with the other antitumor agents
Description

Antineoplastic Agents

Type de données

boolean

Alias
UMLS CUI [1]
C0003392
pregnancy or lactating women
Description

Pregnancy | Breast Feeding

Type de données

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
history of hypersensitivity to any of included ingredients (eg. castor oil) ５) patients who are considered not fit for the study by investigators
Description

Hypersensitivity Ingredient | Castor oil allergy | Patients Medically unfit

Type de données

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C1550600
UMLS CUI [2]
C0571232
UMLS CUI [3,1]
C0030705
UMLS CUI [3,2]
C3841806
patients who have severe dysfunction of liver or kidney
Description

Liver Dysfunction Severe | Renal dysfunction Severe

Type de données

boolean

Alias
UMLS CUI [1,1]
C0086565
UMLS CUI [1,2]
C0205082
UMLS CUI [2,1]
C3279454
UMLS CUI [2,2]
C0205082
total bilirubin > 5 x uln
Description

Elevated total bilirubin

Type de données

boolean

Alias
UMLS CUI [1]
C0741494
ast/alt > 5 x uln
Description

Aspartate aminotransferase increased | Alanine aminotransferase increased

Type de données

boolean

Alias
UMLS CUI [1]
C0151904
UMLS CUI [2]
C0151905
creatinine > 2 x uln
Description

Creatinine increased

Type de données

boolean

Alias
UMLS CUI [1]
C0151578
Retour au début de la page

Similar models

Eligibility Locally Advanced or NCT02447328

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
Postmenopausal state
Item
postmenopausal women
boolean
C0232970 (UMLS CUI [1])
Postmenopausal state | Amenorrhea Duration | Hysterectomy | Outpatients | Inpatient | Locally advanced breast cancer | Secondary malignant neoplasm of female breast | Prior antiestrogen therapy failed
Item
postmenopausal: amenorrhea over 12 months prior to the visit 1 or history of hysterectomy ２) outpatient or inpatient with locally advanced or metastatic breast cancer who have failed with prior anti-estrogen therapy.
boolean
C0232970 (UMLS CUI [1])
C0002453 (UMLS CUI [2,1])
C0449238 (UMLS CUI [2,2])
C0020699 (UMLS CUI [3])
C0029921 (UMLS CUI [4])
C0021562 (UMLS CUI [5])
C3495949 (UMLS CUI [6])
C0346993 (UMLS CUI [7])
C0279797 (UMLS CUI [8,1])
C0231175 (UMLS CUI [8,2])
Patients Estrogen receptor positive | Disease Progression Radiography | Status post Prior Therapy | Informed Consent
Item
estrogen receptor positive ４)radiographic progression of disease after the prior therapy ５) patients who agree to participate in this study and sign the informed consent
boolean
C0030705 (UMLS CUI [1,1])
C0279754 (UMLS CUI [1,2])
C0242656 (UMLS CUI [2,1])
C0034571 (UMLS CUI [2,2])
C0231290 (UMLS CUI [3,1])
C1514463 (UMLS CUI [3,2])
C0021430 (UMLS CUI [4])
Item Group
C0680251 (UMLS CUI)
fulvestrant
Item
patients who are treated with fulvestrant
boolean
C0935916 (UMLS CUI [1])
Antineoplastic Agents
Item
patients who are being treated with the other antitumor agents
boolean
C0003392 (UMLS CUI [1])
Pregnancy | Breast Feeding
Item
pregnancy or lactating women
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Hypersensitivity Ingredient | Castor oil allergy | Patients Medically unfit
Item
history of hypersensitivity to any of included ingredients (eg. castor oil) ５) patients who are considered not fit for the study by investigators
boolean
C0020517 (UMLS CUI [1,1])
C1550600 (UMLS CUI [1,2])
C0571232 (UMLS CUI [2])
C0030705 (UMLS CUI [3,1])
C3841806 (UMLS CUI [3,2])
Liver Dysfunction Severe | Renal dysfunction Severe
Item
patients who have severe dysfunction of liver or kidney
boolean
C0086565 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C3279454 (UMLS CUI [2,1])
C0205082 (UMLS CUI [2,2])
Elevated total bilirubin
Item
total bilirubin > 5 x uln
boolean
C0741494 (UMLS CUI [1])
Aspartate aminotransferase increased | Alanine aminotransferase increased
Item
ast/alt > 5 x uln
boolean
C0151904 (UMLS CUI [1])
C0151905 (UMLS CUI [2])
Creatinine increased
Item
creatinine > 2 x uln
boolean
C0151578 (UMLS CUI [1])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial